These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32781251)

  • 1. Androgen receptor and uterine histoarchitecture in a PCOS rat model.
    Gisela S B; M Virginia A; Gabriela A A; M Virginia T; Enrique H L; Laura K; Véronica L B
    Mol Cell Endocrinol; 2020 Dec; 518():110973. PubMed ID: 32781251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperandrogenism Induces Histo-Architectural Changes in the Rat Uterus.
    Bracho GS; Altamirano GA; Kass L; Luque EH; Bosquiazzo VL
    Reprod Sci; 2019 May; 26(5):657-668. PubMed ID: 29929445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS).
    Neisy A; Zal F; Seghatoleslam A; Alaee S
    Reprod Fertil Dev; 2019 Jan; 31(2):315-323. PubMed ID: 30103849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
    Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
    J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.
    Wang L; Wang YD; Wang WJ; Li DJ
    Osteoporos Int; 2009 Jan; 20(1):79-92. PubMed ID: 18690485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
    Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
    Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
    Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
    J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
    Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
    J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
    Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
    Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin.
    Olaniyan OT; Bamidele O; Uche S; Femi A; Ayobami D; Ayoola O; Builders M; Mali PC
    JBRA Assist Reprod; 2020 Jan; 24(1):41-54. PubMed ID: 31608617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Rho A/Rho-kinase pathway in the uterus of the rat model of polycystic ovary syndrome.
    Aktas S; Un I; Omer Barlas I; Ozturk AB; Ilkay Karagul M
    Reprod Biol; 2019 Mar; 19(1):45-54. PubMed ID: 30704840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus.
    Weihua Z; Ekman J; Almkvist A; Saji S; Wang L; Warner M; Gustafsson JA
    Biol Reprod; 2002 Aug; 67(2):616-23. PubMed ID: 12135905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.
    Kupreeva M; Diane A; Lehner R; Watts R; Ghosh M; Proctor S; Vine D
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E16-E33. PubMed ID: 30153063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine histopathology and steroid metabolism in a polycystic ovary syndrome rat model.
    Bracho GS; Acosta MV; Altamirano GA; Alcaraz MR; Montemurro M; Culzoni MJ; Rossetti MF; Kass L; Luque EH; Bosquiazzo VL
    Mol Cell Endocrinol; 2024 May; 585():112198. PubMed ID: 38467370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical studies on the proliferative marker Ki-67 and estrogen receptor alpha (ERα) in the uterus of neonatal and immature pigs following exposure to flutamide.
    Knapczyk-Stwora K; Durlej M; Bilinska B; Slomczynska M
    Acta Histochem; 2011 Sep; 113(5):534-41. PubMed ID: 20598360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
    Wu H; Zhao B; Yao Q; Kang J
    J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
    Zhang Y; Hu M; Meng F; Sun X; Xu H; Zhang J; Cui P; Morina N; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
    EBioMedicine; 2017 Apr; 18():157-170. PubMed ID: 28336389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
    Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
    Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of morphological changes and steroid receptors in the uteri of postmenopausal women.
    Teresiński L; Sipak O; Rył A; Masiuk M; Rotter I; Ratajczak W; Łazowska M; Słomczyńska M; Marchlewicz M; Karakiewicz B; Kram A; Laszczyńska M
    Histol Histopathol; 2019 Jun; 34(6):631-644. PubMed ID: 30426467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.